OOIR: Observatory of International Research

Papers

(The H4-Index of Osteoporosis International is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
The clinician’s guide to prevention and treatment of osteoporosis	410
Global, regional prevalence, and risk factors of osteoporosis according to the World Health Organization diagnostic criteria: a systematic review and meta-analysis	125
Vertebral fracture: epidemiology, impact and use of DXA vertebral fracture assessment in fracture liaison services	73
The impact of fracture liaison services on subsequent fractures and mortality: a systematic literature review and meta-analysis	69
Association between gut microbiota, bone metabolism, and fracture risk in postmenopausal Japanese women	68
The clinical application of high-resolution peripheral computed tomography (HR-pQCT) in adults: state of the art and future directions	63
Romosozumab and antiresorptive treatment: the importance of treatment sequence	57
Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan	51
Role of Wnt signaling and sclerostin in bone and as therapeutic targets in skeletal disorders	45
An assessment of intervention thresholds for very high fracture risk applied to the NOGG guidelines	43
The analysis of osteosarcopenia as a risk factor for fractures, mortality, and falls	43
Comparing three machine learning approaches to design a risk assessment tool for future fractures: predicting a subsequent major osteoporotic fracture in fracture patients with osteopenia and osteopor	41
A systematic review and meta-analysis of efficacy and safety of Romosozumab in postmenopausal osteoporosis	41
High prevalence and undertreatment of osteoporosis in elderly patients undergoing total hip arthroplasty	37
The ASA score predicts infections, cardiovascular complications, and hospital readmissions after hip fracture - A nationwide cohort study	37
Opportunistic Use of Lumbar Magnetic Resonance Imaging for Osteoporosis Screening	36
Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of O	35
Association between exposure to fine particulate matter and osteoporosis: a population-based cohort study	35
How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey	34
The imminent risk of a fracture—existing worldwide data: a systematic review and meta-analysis	34
Racial and gender differences in the relationship between sarcopenia and bone mineral density among older adults	33
The effect on subsequent fracture risk of age, sex, and prior fracture site by recency of prior fracture	32
Development of the Asia Pacific Consortium on Osteoporosis (APCO) Framework: clinical standards of care for the screening, diagnosis, and management of osteoporosis in the Asia-Pacific region	31
The role of diet quality and dietary patterns in predicting muscle mass and function in men over a 15-year period	30
The effects of caffeine on bone mineral density and fracture risk	30

Fracture risk following bariatric surgery: a systematic review and meta-analysis	29
The global approach to rehabilitation following an osteoporotic fragility fracture: A review of the rehabilitation working group of the International Osteoporosis Foundation (IOF) committee of scienti	29
Current status and distribution of hip fractures among older adults in China	29
Risk of fractures in primary hyperparathyroidism: a systematic review and meta-analysis	28
Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis	28